From April 1, 2022 to June 30, 2022, the company has repurchased 5,479,000 shares, representing 4.77% for $93.58 million. With this, the company has completed the repurchase of 7,792,000 shares, representing 6.76% for $143.22 million under the buyback announced on January 24, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.9 USD | -0.63% | +3.82% | -24.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.79% | 856M | |
+3.77% | 32.18B | |
+14.14% | 7.33B | |
+21.27% | 3.83B | |
-14.80% | 3.23B | |
-26.92% | 1.25B | |
-34.43% | 1.12B | |
+2.23% | 912M | |
-38.47% | 859M | |
-19.51% | 661M |
- Stock Market
- Equities
- MDRX Stock
- News Veradigm Inc.
- Tranche Update on Allscripts Healthcare Solutions, Inc.'s Equity Buyback Plan announced on January 24, 2022.